Banco Santander SA (SAN)

[Huggy Bear]

I hope they continue thru 2014 but no telling honesty.

[whizent1]

Can't say...wished they kept going with that at least one two more times...wishful thinking, though.

[Huggy Bear]

Well at least it is a solid stock. I wonder how many more quarters the special divi will last?

[whizent1]

Hey sorry for not getting back to you...apparently I missed the boat this time around, according to my broker. Got in too late to qualify for that dividend.

[Huggy Bear]

Did you get your dividend shares issues resolved?

[Huggy Bear]

No problem. I know that some brokers post the shares slower than others. Hopefully they had your instructions correct.

[whizent1]

Ok.I'll call to see what's up.Thanks for the reply.

[Huggy Bear]

That varies by broker. You have not received your shares since last quarters dividend yet? I received my about 10 market days ago if I had to guess. Anyway, mine are in there now.

Might want to call your broker on Monday to make sure they had your dividend directions correct. Did you see any extra cash come up in your account for no odd reason? That happened to me once when they did not clearly understand I want the shares EVERY TIME while that special offer still lasts.

They have me set up to take that option automatically since and I don't have to call them or anything.

[whizent1]

When are the divi's supposed to post to our accounts?

[Huggy Bear]

SAN news.

BOSTON, May 27, 2014 /PRNewswire/ -- Nine universities in the United States and Latin America received grants from Santander Universities for study abroad and exchange programs under President Obama's 100,000 Strong in the Americas initiative. Santander Universities, a division of Santander Bank, N.A., has committed $1 million over four years to support the educational exchange program being implemented by Partners of the Americas Foundation, one of the organizations the Department of State selected to implement President Obama's initiative.





The 100,000 Strong in the Americas initiative aims to foster the exchange of university students in the United States with their peers in Latin America and the Caribbean, with the goal of reaching 100,000 exchanges a year by 2020.

"We are delighted to support President Obama's 100,000 Strong in the Americas initiative through our unique universities network and through these grants," said Roman Blanco, president and CEO of Santander US. "By supporting international education programs, we are investing in our future and preparing students to be leaders in our global workforce."

The announcement follows Roman Blanco's participation this month in the President's Education Roundtable at the White House on strengthening education and workforce development in the Western Hemisphere.

Funding for this round of grant recipients was provided by Santander and was open to higher educational institutions that promote study abroad or exchange programs in the Western Hemisphere.

The following nine colleges and universities that received grants will partner with higher educational institutions in Bolivia, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Trinidad and Tobago, and the United States.
•California State University Long Beach in Long Beach, California
•Edgewood College in Madison, Wisconsin
•Montclair State University in Montclair, New Jersey
•North Carolina State University in Raleigh, North Carolina
•Northeastern University in Boston, Massachusetts
•University of Colorado in Boulder, Colorado
•University of South Dakota in Vermillion, South Dakota
•Universidad de La Salle in Bogota, Colombia
•Universidad de San Andres in Buenos Aires, Argentina

The announcement was made at a workshop attended by over 200 higher education leaders in San Diego, California on May 25 in conjunction with the NAFSA: Association of International Educators' annual conference. The workshop focused on creating and maintaining successful study abroad and exchange programs with previous grant recipients of the 100,000 Strong program. Participants included Kathleen Kennedy Townsend, special advisor for 100,000 Strong in the Americas, U.S. State Department; Steve Vetter, president, Partners of the Americas; Marlene M. Johnson, executive director and CEO, NAFSA: Association of International Educators; and Eduardo Garrido, director of Santander Universities US.

This is the first year of a four-year agreement with the Partners of the Americas Foundation to support the 100,000 Strong in the Americas initiative.

http://finance.yahoo.com/news/nine-universities-receive-study-abroad-150300598.html

[Huggy Bear]

To each their own. Any form of dividends is better than none.

[taintedfud]

Rate: Approximately 0.15 Euros per share equivalent to approx. 0.207060 USD per ADR

Option# 1 Stock: (Subject to ADR fee 0.035 per ADS, Not Subject to 21 % Spanish with holding Tax)

Option# 2 Proceeds from sale of rights (Subject to ADR Fee 0.0025 per ADS & Not Subject to 21 % Spanish with holding Tax)

Option# 3 Cash: (fixed rate of approx 0.15 euro per share equating to an approx. net rate of $ 0.161077 ADS & Subject to 21% Spanish With holding tax, Subject to ADR Fee 0.0025 per ADS)
NRate: Approximately 0.15 Euros per share equivalent to approx.

those adr fees are not small. 0.035 of 0.15 is over 20% of the san donation. it is a tax deduction(i think, but not a tax credit.

the .0025 adr fee on door #2 is also not tax deductable. it is sort of small. the 21% spanish tax showesup as a tax credit.

option #3 also looks decent. i have always taken stock before. i think i got tooken. i think it the worst chose i will think about 2 &3 some more.

[Huggy Bear]

Sorry I missed your post. I always opt for shares in lieu of cash. Avoids all tax liabilities. SAN really waking up as of late.

[Turtle_0]

Hey what option 1 2 or 3 did everyone choose for the stock?

3 obviously sounds crazy due to tax inefficiency
1 sounds the best. What do you guys think? Thanks

[Huggy Bear]

Scottrade also takes care of my choice to take the shares every quarter they are offered instead of the default cash divi option.

Nice not to have to remember to call every quarter in time.

[catty]

malc: already done. I requested to automatically do this. As a matter of fact, I have alll my divis reinvested in company stocks. However, with SAN I always double check. Ameritrade is very good about this.

[Huggy Bear]

Dividend instruction time again.

https://east-myservice.broadridge.com/UniversalPortal/ReorgMob/reorgstrt/0114/E79528/05964H/c/index.html?id=&expire=1

Take the shares IMO, avoid the double tax.

[catty]

malc:I'm rather new to the stock, got in only a few months ago, so I'm not familar with the Zackovia deal. But so far, I'm impressed -

[Huggy Bear]

Their actions to shareholders all throughout the really rough times proved it. The selloff of performance based assets at profits and acquiring Zackovia was brilliant.

[catty]

malc: The reason I go into SAN was because it was a global bank. If it was just a Spanish bank I never would have touched it. Another reason is I feel they are very stock holder friendly.

[Huggy Bear]

I am of the opinion that if the EU shows stronger recovery in 2014 then SAN will be a sixteen dollar stock again. It doesn't matter to the market that 51% of Santander's revenue is generated in South and Latin America and with a small but growing US presence, the market perceives Santander to be tied to Spain primarily.

In the meantime I will continue to collect shares in lieu of cash dividend as long as this option is available.

[catty]

It's holding very well

[catty]

SAN has a branch on E 42nd St. in NYC.

[TheFinalCD]

Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

[Huggy Bear]

SAN on the NYSE is the US ADR for Banco Santander in Spain.

[TheFinalCD]

FDA Grants Priority Review for Genzyme’s Cerdelga™ (eliglustat), an Investigational Oral Therapy for Gaucher Disease







Print


Alert



Banco Santander Chile (NYSE:SAN)
Intraday Stock Chart

Today : Wednesday 11 December 2013
Click Here for more Banco Santander Chile Charts.
- Second Major Regulatory Filing Following EMA Acceptance in Late October -

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the Food and Drug Administration (FDA) has granted a six-month Priority Review designation to its New Drug Application (NDA) for Cerdelga™ (eliglustat), an investigational oral therapy for adult patients with Gaucher disease type 1. As previously announced, the European Medicines Agency in late October validated Genzyme’s marketing authorization application (MAA) for eliglustat in the EU.

Genzyme is developing eliglustat, a capsule to be taken twice daily, to provide an effective oral treatment alternative for adult patients with Gaucher disease type 1, and to provide a broader range of treatment options for Gaucher patients and physicians. Genzyme’s clinical development program for eliglustat represents the largest clinical program ever conducted in Gaucher disease, with approximately 400 patients treated in 29 countries.

“The acceptance of our applications for Cerdelga represents another important milestone in our commitment to understand and respond to the needs in the Gaucher community, providing more choice for the treatment of patients,” said Genzyme’s President and CEO David Meeker, M.D.

The marketing applications for Cerdelga are based on two positive Phase 3 studies for eliglustat, ENGAGE, which included patients new to therapy, and ENCORE which included patients switching from enzyme replacement therapy. The submissions also include four years of safety and efficacy data from the eliglustat Phase 2 study.

About Gaucher disease

Gaucher disease is an inherited condition affecting fewer than 10,000 people worldwide. People with Gaucher disease do not have enough of the enzyme, ß-glucosidase (glucocerebrosidase) leading to the accumulation of its substrate, glucosylceramide. As a result, lipid engorged cells (called Gaucher cells) amass in different parts of the body, primarily the spleen, liver and bone marrow. Accumulation of Gaucher cells may cause spleen and liver enlargement, anemia, excessive bleeding and bruising, bone disease and a number of other signs and symptoms. The most common form of Gaucher disease, type 1, generally does not affect the brain.

About eliglustat

Eliglustat, an investigational new drug, is a novel ceramide analog given orally and was designed to partially inhibit the enzyme glucosylceramide synthase, resulting in reduced production of glucosylceramide. Glucosylceramide is the substance that builds up in the cells and tissues of people with Gaucher disease. The concept was initially developed by the late Norman Radin, MD, from the University of Michigan. In pre-clinical studies, the molecule, developed with James A. Shayman, MD, also from the University of Michigan, has shown high potency and specificity.

About Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. That goal guides and inspires us every day. Genzyme’s portfolio of transformative therapies, which are marketed in countries around the world, represents groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Learn more at www.genzyme.com.

Genzyme® and Cerdelga™ are registered trademarks of Genzyme Corporation. All rights reserved.

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

[Huggy Bear]

I have not seen any commercials but I doubt I am in the target zone down here in AR. Do not expect to see any branches here in the near future.

Community involvement and corporate philanthropy are top priorities at Santander, which made over $11 million in grants and donations to non-profit organizations in the United States in 2012.

But yeah, they are trying to make a footprint in the US. Nominal activity here compared with other areas such as Latin America. Latin America is where the growth has been that has staved off Santander from much more dire circumstances during the height of the EU crisis.

[catty]

malc: one of the reasons I got into SAN is that it's not just Spain, but Global ... including the USA. As a matter of fact, don't know if you've seen their TV commercial which runs on CNBC. Unfortunately it's not very memorable, or impressive.

[Huggy Bear]

I received my shares in lieu of cash dividend in my account last week. A bit disappointed that the ratio is no longer 1 for every 36 but not complaining. "They" say Spain is emerging from recession, but I do not consider a single positive quarter GDP wise as a tell all sign, Spain still has unemployment of around 20%. Nevertheless the financial situation with the bank is dramatically improving as losses from non performing and defaulted real estate loans in the Euro sector are being written off the books aggressively and the 50% diversification into Latin America still performing well across the board with 7-9% growth there. The investment into Poland in the heyday of Euro unrest was brilliant IMO and will lend to the EU portfolio overall stability.

I would not be surprised at all to see Santander approach a FMV of around 14-16/sh. within the next 12-18 months. It is a long term hold for me, how long is undetermined as it all depends on how it looks past FMV - The actions of management in the times of trouble may pay off way past the recovery in the EU.

[catty]

the dividends just showed up in my Ameritrade acct. Nice!

[Huggy Bear]

BOSTON, Oct. 21, 2013 /PRNewswire/ -- Santander Group Chairman Emilio Botin announced the Bank's commitment, through its Santander Universities Global Division, to contribute $100 million to U.S. universities during the next five years.

In a recent presentation at Lincoln Center in New York attended by university leaders and researchers, Emilio Botin said: "At Santander we strongly believe that education is the best way to invest in the future. For us, it is also the best way to show our long-term commitment to the communities in which we work. Sixteen years ago, we began an alliance with the academic world that is unprecedented in international finance."

Regarding cooperation with U.S. universities, he said: "We are delighted to be working with 27 U.S. universities. U.S. universities are, without doubt, an example worldwide. Our cooperation with U.S. universities has been key for the development and growth of Santander in this country. Today we are enhancing our commitment to American society."

Santander's contribution of $100 million over the next five years will go toward academic and research projects, exchange programs and improving the relationship with and services to the university community.

The funds will support initiatives such as the granting of 5,000 international exchange grants for students, lecturers and researchers, and the implementation of joint research projects between U.S. universities and institutions in Asia, Europe and Latin America. The Bank will also contribute $1 million to the U.S. government's "100,000 Strong for the Americas" initiative, which will facilitate 100,000 student exchanges each year between the U.S. and Latin America and the Caribbean.

The Bank supports these and other initiatives via its Santander Universities Global Division. The activities of Santander Universities Global Division form the backbone of the Bank's community activities and enable it to maintain a stable alliance with more than 1,040 universities and research centers worldwide. Santander Universities began its support for higher education in the U.S. in 2009 and currently has 27 agreements with educational institutions in the country.

[Huggy Bear]

Why do they always post news here and it is never about Santander? Cracks me up.

The loading zone in the mid six buck range was dead on.

[catty]

maic: thanks. I will ... they don't seem to know anything about it.

[Huggy Bear]

Seriously, your local TD office just needs to call the main office. All major brokerages have access to any special ADR instructions, you just have to prompt them to do it. If not you just get a rather sorry cash divi in comparison.

[catty]

maic: thanx

[Huggy Bear]

No

[catty]

maic: this may sun dumb, but I'll askuy anyway: "If I don't do anaything, will I get the bonus shars?"

[Huggy Bear]

The first time my ST broker had to check with the main national office. Or you might could email him the link to the special offering.

[catty]

maic: just checked Ameritrade and they have no information re the special stock dividend -will check them again next week. Any feedback? However, I did enroll in their DRIP program Thanks.

[Huggy Bear]

No problem. Just remember they don't round up with shares divi so keep it a multiple of 36 would be my advice for your position.

[catty]

maic: thanks..will call my broker. sounds interesting

[Huggy Bear]

Dear Customer,

You have elected to receive shareholder information electronically. This e-mail notification contains information specific to your holding in the security identified below. Please read the instructions carefully before proceeding.

This is notification of: SPECIAL DIVIDEND ELECTION for BANCO SANTANDER, S.A.
The offer is made by BANCO SANTANDER, S.A. and it expires on October 22, 2013. You are required to reply to your Scottrade branch office by 10/15/13.


Quantity: 76.000000
CUSIP Number: 05964H105
Scottrade Account Number: *****346
Control Number: 043911410015
Job Number: E77848

You may view additional information at the following Web site(s):

Offer
https://myservice.broadridge.com/UniversalPortal/ReorgMob/reorgstrt/0913/E77848/05964H /c/index.html?id=&expire=1


Your position in the above security is currently being held in your account at our firm. We will need to receive instructions from you only if you wish to participate in this offer. The terms and conditions of this offer are outlined on the above Web site. Please read carefully. As a holder of your securities, we will forward your instructions, should you choose to participate in this offer.

Unless we have otherwise advised you, it is imperative that we receive your instructions no later than the above reply date in order to properly fulfill them. Any instructions received after that time will be processed on a "best efforts" basis only. Please be advised we cannot act without your instructions and will not be held liable for any instructions that are received after the processing deadline. The reply date is prior to the expiration in order for us to process your instructions. Any information given by us, either verbally or in writing, is intended as a guide and is not to be used as the basis for any decision regarding this offer.

You are responsible for full compliance with the terms of this offer. In the event of a discrepancy between these terms and the offer materials, please note the offer materials will prevail. No written instructions will be accepted; verbal instructions (no voice mail) must be given directly to a broker. For us to act on your behalf, your account must have the necessary shares or funds fully settled and unrestricted. Online Accounts are charged a $25.00 fee to process a voluntary reorganization (this fee does not apply to Dividend Elections).

Do not reply to this e-mail; contact your Scottrade branch office if you have any questions.

If you have read up here before investing you already know the advantages of taking the shares instead of the cash dividend. The ratio has been one share for every 36 owned for five quarters or more. It is a quarterly dividend and great way to build a free position in the time of recovery in the EU. It won't last forever. If you bought in today you must contact your broker and give them instructions on how you wish to take your dividend. You got in for this quarters offer I believe and should be eligible. I get this letter every quarter, but my broker already knows I want the shares so I don't have to call every quarter. The shares will take a long time to be reflected in your account so don't stress if you do not see them immediately after the offer period expires. Best wishes. malc.

[Huggy Bear]

I will post you the latest shareholder letter with the details when I get home later. I think yur allgood. Buy in blocks of 36 to maximize dividend.

[catty]

maic: Just got in. Question: Is it automatically reinvested in your account? Also, am I eligible since I just bought in today? Thanks.

[RickKayne]

Missed it.

[Huggy Bear]

Shares in lieu of cash dividend announced again this quarter, time to add while the price is down.

[Huggy Bear]

Dividend shares showed up in my account last week, pending.

Thanks Santander for the optional shares in lieu of double taxed divis.

[Short_moneyC3]

Any speculations on the special dividend in April?

[Huggy Bear]

The explanation for the drop, from my reading of the 6-K, was bottom line dismal earnings, at least in the eyes of the general market that does not, in general, do much DD and tends to go with general market movement.

Grupo Santander registered net attributable profit of EUR 2,205 million in 2012, 59% less than in 2011. Ordinary profit was EUR 5,251 million, while capital gains came to EUR 1,065 million, mainly from the sale of the Colombian unit and the reinsurance of the Spanish and Portuguese life insurance portfolios. Profit for the year would have been EUR 6,315 million, but after setting aside a net EUR 4,110 million to cover real estate exposure in Spain, fell to EUR 2,205 million.

Banco Santander’s Chairman Emilio Botín said: “Profits reached a turning point in 2012. In 2013, with the exceptional write-offs behind us, we should see a marked increase in earnings, based on the group’s recurrent revenues and cost control.”

[taintedfud]

any explanation in all this report as to why the stock has had an immense dump and crash after the x div date? 2-3x normal trading, and a 10+%drop in price this week??? and into an up market.

is there a SAN message board that is more active than this one? at least this one does not have a million pumpers.

SAN is one of my major holdings. information on activity is difficult for me to find.

i think there was inside information somewhere, as the calls for jan '13 were very expensive. i sold covered calls in july '12 for jan 13.